Clinical research,
built better for all.

Today, clinical research is broken.

Inequitable.     Fragmented.     Inefficient.     Costly.

We're building the platform of tomorrow and changing the paradigm for patient care.   A new, efficient ecosystem where less physician burden translates to wider patient access and accelerated study timelines.  Our mission is to create equitable access to the best possible care for any patient anywhere.

 

Get the latest on our launch and stay in touch with us.
Sign up
AdobeStock_85674771
GettyImages-1330481753
GettyImages-644187477 (2) (2)
GettyImages-1131369293
Who we are

Meet Our Leadership Team

Kent Thoelke

Kent Thoelke

Chief Executive Officer
Jonathan Hirsch

Jonathan Hirsch

Chief Strategy & Growth Officer
Jay Trepanier

Jay Trepanier

Chief Financial Officer
Elijah Meerson

Elijah Meerson

Chief Technology Officer

Board of Directors

Robert Nelsen

Robert Nelsen

Co-founder and Managing Director, ARCH Venture Partners
Hemant Taneja

Hemant Taneja

CEO and Managing Director, General Catalyst
Stephen Knight

Stephen Knight, MD

President and Managing Partner, F-Prime
Kenneth C. Frazier

Kenneth C. Frazier

Former Executive Chairman & CEO, Merck
General Gustave F. Perna

General (Ret) Gustave F. Perna

Former COO, Operation Warp Speed
Stephen Klasko

Stephen Klasko, MD MBA

Former CEO, Jefferson Health
Jay Markowitz

Jay Markowitz, MD

Former SVP R&D, Regeneron
Luciana Borio

Luciana Borio, MD

Former Chief Scientist, U.S. Food & Drug Administration
Elena Viboch

Elena Viboch

Partner, General Catalyst
Kent Thoelke

Kent Thoelke

CEO, Paradigm
Our investors include:

Leading funds backing our vision of a completely new healthcare and drug development paradigm